Search

A recent study conducted at Friedrich-Alexander-University Erlangen-Nurnberg (FAU) explored the dynamics of CAR T-cells in patients with systemic sclerosis and myositis. The research focused on Hu19-CD828Z, a CAR T-cell therapy designed to deplete B-cells, showing promising results in vitro. The study suggests that this therapy could be a potential treatment strategy for autoimmune diseases like systemic lupus erythematosus, idiopathic inflammatory myositis, and systemic sclerosis. For more information, the full article can be accessed for free at the International Journal of Molecular Sciences website. [Extracted from the article]

Researchers from Universitas Negeri Surabaya conducted a systematic review to investigate the potential of polyphenol compounds in grapes to reduce oxidative stress and inflammation after exercise-induced muscle damage. The study involved screening 2947 articles and analyzing 8 selected ones, which showed that grape polyphenols have antioxidant and anti-inflammatory properties. These compounds were found to reduce oxidative stress by lowering ROS, MDA, and TBARS levels, while also decreasing inflammation by blocking inflammatory pathways and reducing inflammatory markers. The research suggests that grapes could be beneficial in alleviating muscle pain and reducing uncontrolled inflammation post-exercise. [Extracted from the article]

Researchers at the University of South Dakota have conducted a study on the role of proBDNF as a myokine in skeletal muscle injury-induced inflammation. The study found that proBDNF is released from skeletal muscle into circulation following injury and plays a significant role in inflammation through its receptor, p75(NTR). The researchers suggest that modulation of p75(NTR) with a small-molecule modulator, LM11A-31, could be a potential therapeutic approach against injury and inflammation. This study provides new insights into the molecular mechanisms underlying skeletal muscle injury and inflammation. [Extracted from the article]

A patent application titled "Treatment Of Inclusion Body Myositis With Adipose-Derived Regenerative Cells" has been published online, focusing on using adipose-derived regenerative cells (ADRC) as a treatment for inclusion body myositis (IBM), an inflammatory muscle disease that primarily affects older adults. The method involves obtaining ADRC and administering them to the subject with IBM, potentially offering a new treatment option for a condition that currently lacks approved therapies. The patent application outlines detailed procedures for obtaining, isolating, and administering ADRC, as well as monitoring the treatment's effectiveness through biomarkers and functional assessments. [Extracted from the article]

A recent report from Johns Hopkins University discusses the role of muscle magnetic resonance imaging (MRI) in evaluating idiopathic inflammatory myopathies (IIMs), which are muscle disorders characterized by weakness, inflammation, and autoimmunity. The study highlights the importance of advanced quantitative MRI techniques in assessing disease activity and monitoring key imaging features such as muscle edema and damage. Researchers aim to provide new insights into the diagnosis and assessment of IIMs through the application of MRI technology. [Extracted from the article]

A recent study conducted at Murdoch University in Australia focused on Inclusion Body Myositis (IBM), an inflammatory myopathy characterized by muscle weakness and atrophy. The research aimed to identify the most effective outcome measures for tracking disease progression and intervention response in clinical trials. The study found that the IBM Functional Rating Scale (IBMFRS), neuromuscular symptom score (NSS), two-minute walk test (2MWT), and modified timed up and go (mTUG) were the best predictors of patient-perceived physical function in IBM. This research has been peer-reviewed and provides valuable insights for clinicians and researchers in the field of neuromuscular disorders. [Extracted from the article]

A recent study conducted at Capital Medical University in Beijing, China, focused on the development of a machine learning model to predict the rapid progression of interstitial lung disease in patients with idiopathic inflammatory myopathy. The researchers utilized quantitative computed tomography (QCT) and clinical features to create a predictive model, which outperformed models based solely on QCT or clinical data. The study concluded that incorporating clinical data alongside QCT features could further enhance the prediction performance. This research was supported by the National Natural Science Foundation of China and has been peer-reviewed. [Extracted from the article]

A report from the University of Utah discusses a case of myositis ossificans in a collegiate golfer experiencing persistent ulnar-sided hand pain. Despite conservative treatment, the patient's symptoms did not improve until receiving an ultrasound-guided fenestration and injection of lidocaine and dexamethasone. The research highlights the importance of considering myositis ossificans in cases of ongoing muscular pain and the challenges related to ulnar-sided hand anatomy. This information was published in the American Journal of Physical Medicine & Rehabilitation and can be accessed online. [Extracted from the article]

A study conducted at Paijat-Hame Central Hospital in Lahti, Finland, examined the predictive value of myositis antibodies in diagnosing myositis and related conditions. The research found that different antibodies had varying predictive values for different conditions, with stronger band intensities and the presence of multiple antibodies increasing the predictive value. The study highlights the importance of considering antibody characteristics in diagnosing myositis and related diseases. For more information, the full article can be accessed at https://doi.org/10.1136/rmdopen-2024-005007. [Extracted from the article]

Researchers at the Universitat Oberta de Catalunya have found that turmeric and its active component, curcumin, may help reduce muscle damage and inflammation following intense physical exercise. Studies have shown that curcumin has antioxidant and anti-inflammatory properties, making it beneficial for muscle recovery and pain reduction. While curcumin intake within a specific dosage range can enhance muscle recovery, further research is needed to fully understand its effects on different populations and circumstances. [Extracted from the article]

The article discusses a study on Fibrodysplasia ossificans progressiva (FOP), a condition characterized by abnormal bone formation in soft tissues. The research used multi-omics analyses to uncover global signaling alterations in cells with a specific mutation linked to FOP, identifying dysregulated Activator Protein-1 (AP-1) as a potential therapeutic target. The findings suggest that targeting AP-1 could help reduce osteochondrogenic differentiation associated with FOP. The study has not yet undergone peer review and provides valuable insights into the pathogenesis of FOP. [Extracted from the article]

A recent study conducted at the University Hospital Infanta Sofia focused on disease activity in patients with idiopathic inflammatory myopathy (IIM) based on time since diagnosis and positivity to antisynthetase autoantibodies (ASAs). The study included 554 patients with different diagnostic subgroups of IIM, with higher disease activity observed in incident cases compared to prevalent cases. The research concluded that recent diagnosis is associated with greater disease activity, and certain measures of activity outcomes could be used across various subtypes of IIM. The findings suggest that PhGA and extramuscular activity are not affected by ASA positivity, supporting their use in assessing treatment response in IIM with ASAs. [Extracted from the article]

A recent study conducted at Nara Medical University in Kashihara, Japan, highlighted a rare case of a 78-year-old man experiencing overlapping durvalumab-induced myositis, Takotsubo-like morphological changes caused by myocarditis, and myasthenia gravis. The patient initially required invasive ventilation and exhibited symptoms of myasthenia gravis after treatment with high-dose steroids but achieved successful recovery after receiving intravenous immunoglobulin, plasmapheresis, and high-dose steroids. The research emphasizes the importance of vigilant neurological monitoring for patients with immune checkpoint inhibitor-induced myositis to promptly initiate treatment for myasthenia gravis. [Extracted from the article]

A study conducted by researchers at Lanzhou University in China explores the role of neutrophil extracellular traps (NETs) in promoting epithelial-mesenchymal transition (EMT) in alveolar epithelial cells through Toll-like receptor 9 (TLR9) signaling. The research, which utilized an experimental autoimmune myositis (EAM) mouse model, suggests that NETs-induced EMT may be a key pathogenic mechanism in idiopathic inflammatory myopathy-associated interstitial lung disease (IIM-ILD), with TLR9 signaling playing a significant role. Targeting TLR9 signaling could potentially offer a promising therapeutic approach for IIM-ILD. [Extracted from the article]

A recent study conducted at Habib Bourguiba University Hospital focused on the detection of multiple myositis-specific antibodies (MSAs) and their clinical significance. The research found that the multipositivity of MSAs is uncommon, with only 15.7% of patients testing positive for at least 2 MSAs. The study highlighted the importance of considering MSA number, level of positivity, and clinical data in interpreting results. The findings suggest that detecting multiple MSAs using immunodot techniques can provide valuable insights for diagnosing and managing myositis. [Extracted from the article]

Researchers from Shanxi Bethune Hospital conducted a study on myasthenia gravis and idiopathic inflammatory myopathies, autoimmune disorders that can co-occur. The study aimed to identify common differentially expressed genes between the two conditions to understand shared pathogenic pathways and potential therapeutic targets. Four co-DEGs associated with neurotransmitter transport and ion channel regulation were identified, and a nomogram model showed high predictive accuracy for diagnosing myasthenia gravis with inflammatory myopathies. Further experimental validation is needed to confirm these findings. [Extracted from the article]

The article discusses a gene therapy study conducted by Sarepta Therapeutics Inc., focusing on immune-mediated myositis following delandistrogene moxeparvovec gene therapy. The study found that patients with DMD gene deletions involving specific exons may be at increased risk of immune-mediated myositis after receiving the gene therapy infusion. The research highlights the importance of understanding immune responses to gene therapy products for effective treatment. [Extracted from the article]

A study conducted at Gifu University in Japan explored the case of a 69-year-old woman with breast cancer who developed immune checkpoint inhibitor-related myositis after treatment with pembrolizumab. Despite the absence of dysphagia symptoms, the patient exhibited esophageal dysfunction, which improved partially with immunotherapy. The research suggests that esophageal dysfunction may be an unrecognized complication of ICI-related myositis, highlighting the importance of monitoring and managing such conditions. [Extracted from the article]

The article discusses the development of a CRISPR-Cas13b gene therapy system to target the DUX4 gene in patients with Facioscapulohumeral muscular dystrophy (FSHD). While the therapy showed initial efficacy in reducing DUX4 levels and protecting cells in a mouse model, sustained efficacy was challenged by a decrease in Cas13b and guide RNA levels over time. Additionally, the study found that the therapy triggered immune responses in mice and human FSHD myoblasts, indicating the need to address immune reactions for successful implementation of CRISPR/Cas13-based gene therapies. [Extracted from the article]

A study conducted at Kurashiki Medical Center in Japan focused on a case of a woman in her late 70s presenting with fever, rashes, and muscle weakness, initially thought to be noninfectious conditions like myositis and vasculitis. Treatment with cephalosporins was ineffective, but symptoms improved with minocycline, indicating possible Japanese spotted fever (JSF) despite no history of tick exposure. The research highlights the importance of considering JSF in patients with atypical symptoms and starting timely treatment to prevent severe complications. [Extracted from the article]

Researchers at Huazhong University of Science and Technology in Wuhan, China, have conducted studies on obesity, focusing on the impact of inflammation on skeletal muscle and the development of fibrosis. The research highlights the connection between obesity, inflammation, and metabolic disorders such as insulin resistance and type 2 diabetes. Intervention strategies such as aerobic exercise, dietary modifications, and pharmacotherapy are suggested to improve skeletal muscle inflammation and fibrosis. This study aims to provide new insights into the treatment and management of metabolic diseases associated with obesity and insulin resistance. [Extracted from the article]

Researchers at Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University have published a new study on rheumatoid arthritis, focusing on the management of focal myositis. The study discusses a 58-year-old patient with rheumatoid arthritis who was diagnosed with focal myositis during standard immunosuppressive therapy and successfully treated with tofacitinib. The research suggests that tofacitinib could be considered as an alternative therapeutic strategy in cases where corticosteroid tapering proves difficult. [Extracted from the article]

A recent case report and literature review from the University of Cagliari in Italy focused on a rare case of idiopathic orbital myositis in a poorly controlled diabetic patient. The 45-year-old woman presented with eye pain, diplopia, and motility deficits, with MRI revealing signs of inflammation. The study emphasized the importance of MRI as a diagnostic tool for myositis and highlighted the potential link between diabetes and this condition. The researchers called for further research in evidence-based medicine, especially in complex cases like this one. [Extracted from the article]

Researchers from Baylor University College of Medicine in Houston, Texas, have published a report on Inclusion Body Myositis (IBM), focusing on recent advances in understanding the epidemiology, pathophysiology, and management of the condition. The study highlights the morbidity and mortality associated with IBM, including the impact of dysphagia, and identifies new pathogenic pathways and biomarkers for potential use in clinical trials. The research emphasizes the need for new treatment targets beyond exercise, with ongoing clinical trials targeting T cells and autophagy to improve outcomes for individuals with IBM. [Extracted from the article]

Researchers at Lorestan University in Iran conducted a study on the effects of ginger supplementation on inflammatory indicators and muscle damage in obese girls after exercise. The study involved 50 girls with a body mass index over 30 kg/m2 who were divided into different groups and given ginger supplements for four weeks. The results showed that ginger supplementation could potentially reduce inflammation and muscle damage caused by physical activity, particularly in introverted exercise. This research provides valuable insights into the potential benefits of ginger for obese individuals engaging in exercise. [Extracted from the article]

The rare autoimmune disorders market is rapidly evolving due to advancements in biotechnology and a better understanding of immune system dysfunctions. There is a growing demand for targeted therapies as the prevalence of autoimmune diseases increases. Biopharmaceutical companies are investing in developing novel treatments, including biologics, monoclonal antibodies, and gene therapies. Precision medicine is also emerging, allowing for personalized treatment plans based on genetic and molecular profiling. Regulatory bodies are expediting approvals for orphan drugs, promoting innovation and improving access to life-saving treatments for patients with rare autoimmune conditions. DelveInsight has released epidemiology-based market reports on rare autoimmune disorders such as Myasthenia Gravis, Systemic Sclerosis, Axial Spondyloarthritis, and Idiopathic Inflammatory Myositis, providing insights into current treatment practices, emerging drugs, market share, and forecasted market size. [Extracted from the article]

A study conducted at Saitama Children's Medical Center in Japan focused on the diagnostic performance of ultrasound in pediatric patients with suspected myositis and fasciitis, including necrotizing fasciitis. The research found that ultrasound was reliable in detecting abnormal findings and was useful for diagnosing necrotizing fasciitis, which could aid in urgent surgical intervention. The study compared sonographic findings between patients with and without necrotizing fasciitis, highlighting significant differences in peripheral deep fascial edema, width of fluid accumulation, and vascular lumen collapse between the two groups. [Extracted from the article]

A study conducted in Beijing, China, focused on the use of quantitative muscle ultrasound to monitor muscle and fascia inflammatory activity in children with juvenile dermatomyositis (JDM). The research found that ultrasound parameters such as muscle echo intensity, fascia thickness, and muscle microvascular flow imaging distribution were significantly different in children with active JDM compared to those with stable JDM and healthy children. The study concluded that children with unresolved fasciitis may be at risk of developing calcification. This peer-reviewed research provides valuable insights into assessing the activity status of individuals with JDM using ultrasound technology. [Extracted from the article]

A case report from Showa University Fujigaoka Hospital in Japan highlights the successful management of immunotherapy-resistant respiratory failure in a patient with anti-mitochondrial M2 antibody-positive myositis. The patient underwent modified lung volume recruitment (mLVR) therapy, which led to significant improvements in respiratory function and allowed for successful weaning off ventilation. This case suggests that mLVR therapy may be effective in treating severe, immunotherapy-resistant respiratory failure in patients with myositis. The research emphasizes the importance of tailored respiratory rehabilitation for patients with weakened respiratory muscles or tracheostomy. [Extracted from the article]

Researchers from University Hospital in Burton-upon-Trent, United Kingdom, conducted a systematic review on myositis ossificans, a condition characterized by heterotrophic bone formation in muscle tissue, often in response to trauma. The review included 77 papers with information on 89 patients diagnosed with myositis ossificans, showing a predilection for males under 30 years of age. The study found that anatomically confined sites like the hand and foot often required surgical intervention, indicating the need for further research to identify patients who could benefit from earlier consideration of surgery. [Extracted from the article]

A recent study conducted at the General Hospital of Northern Theater Command in Liaoning, China, explores the role of inflammasomes in idiopathic inflammatory myopathies (IIM). The research highlights the involvement of inflammasomes, specifically NLRP3 and AIM2, in the development of IIM and discusses potential therapeutic implications of targeting these inflammasomes. The study concludes that understanding these mechanisms could lead to new avenues for therapeutic intervention and a better comprehension of IIM pathophysiology. For more information, the full article can be accessed for free at the Frontiers in Immunology journal website. [Extracted from the article]

A recent study compared the effectiveness of high-intensity interval training (HIIT) versus standard low-moderate intensity exercise in improving aerobic capacity in patients with recent-onset idiopathic inflammatory myopathies (IIM). The study found that HIIT led to a 16% increase in aerobic capacity, as well as improvements in muscle endurance and mitochondrial function, compared to the standard exercise group. The results suggest that HIIT may be a safe and effective intervention for patients with recent-onset IIM, potentially enhancing their overall health. [Extracted from the article]

Researchers from Ain Shams University conducted a study on adult and juvenile-onset inflammatory myopathy in Egyptian patients, focusing on autoantibodies and muscle MRI. The study analyzed data from 77 patients with clinical manifestations of myositis, detecting 17 myositis autoantibodies and performing whole-body muscle MRI. The research concluded that autoantibodies and MRI are crucial for accurate diagnosis and treatment of myositis subtypes in patients with inflammatory myopathy. For more information, the study was published in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery. [Extracted from the article]

Researchers at Kyushu University conducted a study on Duchenne muscular dystrophy (DMD), the most common type of muscular dystrophy in Japan. They used noninvasive magnetic resonance imaging (MRI) to evaluate inflammation in DMD model mice, focusing on redox alterations. The study found that the reduction rate of redox probes in DMD model mice increased compared to normal mice, indicating muscle fiber damage and inflammation. The researchers concluded that in vivo DNP-MRI is a valuable tool for assessing skeletal muscle inflammation in DMD. [Extracted from the article]

A recent study from the Department of Allergy and Rheumatology in Tokyo, Japan, focuses on the management of myositis-associated interstitial lung disease (ILD). The research highlights risk factors for ILD development in patients with myositis, such as Asian race, dermatomyositis, and specific antibodies. Various prediction models for mortality in patients with myositis-ILD have been proposed, but further validation is needed. The study emphasizes the need for global collaboration to establish consensus algorithms for the treatment of myositis-ILD. [Extracted from the article]

A recent research study conducted by Saglik Bilimleri Universitesi focused on juvenile idiopathic inflammatory myopathy patients to determine factors predicting disease course and the impact of major complications. The study included 30 patients with IIM, with findings showing that the 6th month Childhood Myositis Assessment Scale (CMAS) score was significantly correlated with disease course. The research concluded that the CMAS score is a useful tool in predicting disease course, particularly for patients with low scores who may require careful monitoring for potential complications. [Extracted from the article]

Researchers from Rutgers University conducted a study on nailfold microscopy in adult-onset dermatomyositis in association with myositis antibodies. The study reviewed existing literature and found that characteristic nailfold findings may aid in the diagnosis of dermatomyositis. The research identified prevalent nailfold findings such as increased vascular diameter and decreased vascularity, suggesting potential associations between antibody status and capillaroscopic findings. This peer-reviewed study provides valuable insights into the role of nailfold microscopy in dermatomyositis diagnosis. [Extracted from the article]

Researchers at Huazhong University of Science and Technology have published a study on amyloid myopathy mimicking idiopathic inflammatory myopathy, highlighting the importance of Congo red staining in accurate diagnosis. The case report discusses a 58-year-old man initially misdiagnosed with inflammatory myopathy, whose symptoms worsened after immunotherapy. The research aims to raise awareness about amyloid myopathy to prevent misdiagnosis and emphasize the significance of Congo red staining in similar cases. [Extracted from the article]

A recent study from National Taiwan University Hospital reported a case of recurrent gastric cancer in a 51-year-old female patient who initially presented with dysphagia induced by idiopathic inflammatory myositis. Despite surgical resection and chemotherapy, the disease recurred, leading to laryngeal weakness and features of an autoimmune disorder. The patient was diagnosed with paraneoplastic autoimmune syndrome, specifically dermatomyositis with features of Sjogren's syndrome, highlighting the complexity of managing such conditions in cancer patients. The study emphasizes the need for further investigation into the optimal therapeutic approach for this rare manifestation in gastric cancer patients. [Extracted from the article]

A recent systematic review highlighted a potential link between inflammatory myopathies and celiac disease, suggesting that a gluten-free diet could improve myositis symptoms. A scoping review further explored the pathophysiological connections between inflammatory myopathies and autoimmune gluten-related disorders like celiac disease. The findings suggest a shared genetic predisposition and immune response in some patients, indicating the need for further research and potential dietary interventions for patients with these conditions. [Extracted from the article]

Researchers at the University of Bath conducted a study on myositis patients in the UK, focusing on the presence of anti-Sp4 and anti-CCAR1 autoantibodies in adult and juvenile populations. The study found that these autoantibodies were less common in UK patients compared to those in the USA, limiting their use as biomarkers for cancer risk. The research was supported by various organizations and has been peer-reviewed, providing valuable insights into myositis and its clinical associations. [Extracted from the article]

A study conducted at the People's Hospital of Guangxi Zhuang Autonomous Region in China explored the short-term efficiency of plasma exchange (PE) in combination with immunosuppressants and/or biologics for treating idiopathic inflammatory myopathy with rapidly progressive interstitial lung disease (IIM-RP-ILD). The research found that PE, when combined with other treatments, was effective in improving the survival rate at 6 months and suppressing ILD-related serum markers. The study suggests that PE therapy may have additional supportive effects in treating this challenging disease. [Extracted from the article]

Research from the University of Hong Kong explores the role of brain-derived neurotrophic factor (BDNF) deficiency in causing myositis, a group of immune-related muscle diseases. The study found that mice with muscle-specific BDNF knockout displayed myositis development, characterized by muscle damage and inflammation. The research suggests that insufficient BDNF production in muscle can lead to oxidative stress, necroptosis, and pyroptosis, contributing to the development of myositis. This study highlights potential therapeutic strategies to alleviate myopathies associated with BDNF deficiency. [Extracted from the article]

The research study from "Carol Davila" University of Medicine and Pharmacy in Bucharest, Romania, explores the association between anti-SRP antibodies and myocarditis in systemic sclerosis overlap syndrome with immune-mediated necrotizing myositis. The study highlights the challenges in diagnosing and treating collagen diseases, emphasizing the role of anti-SRP antibodies in cardiac involvement. The findings suggest that while anti-SRP antibodies target muscle fibers, their correlation with cardiac manifestations remains controversial, with myocarditis posing potential severe outcomes. The study underscores the importance of accurate diagnosis and management in overlapping syndromes for improved prognosis. [Extracted from the article]

A recent study from the University of Washington explores the role of mitochondrial transfer in muscle function in idiopathic inflammatory myopathies. Mitochondrial dysfunction is linked to muscle atrophy and decreased endurance, with potential implications for various inflammatory and degenerative disorders. The research highlights the emerging field of mitochondrial transfer technology as a potential avenue for addressing mitochondrial dysfunction and preserving muscle health in conditions like inclusion body myositis and sarcopenia. [Extracted from the article]

A recent report from Stanford University discusses new findings on myositis, a type of inflammation within skeletal muscle. The research highlights the importance of MRI in diagnosing myositis and differentiating it from other conditions that mimic its imaging features. The study also emphasizes the need for integrated analysis of imaging, clinical, laboratory, and pathology data for a definitive diagnosis. This peer-reviewed research provides insights into the terminology, guidelines, and potential future advancements in the evaluation of muscle disorders. [Extracted from the article]